+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long term administration of almitrine bismesylate in chronic obstructive pulmonary disease copd



Long term administration of almitrine bismesylate in chronic obstructive pulmonary disease copd



American Review of Respiratory Disease 135(4 PART 2): A278




(PDF emailed within 1 workday: $29.90)

Accession: 028645588

Download citation: RISBibTeXText


Related references

Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease. American Review of Respiratory Disease 140(5): 1269-1273, 1989

Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease. American Journal of Medicine 84(3 Pt 1): 436-444, 1988

One year administration of almitrine bismesylate (Vectarion) to chronic obstructive pulmonary disease patients: pharmacokinetic analysis. Biopharmaceutics & Drug Disposition 10(3): 247-255, 1989

Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia. Respiratory Medicine 97(6): 599-605, 2003

Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxemia. Chest 118(4 Suppl ): 192S, October, 2000

Long term trial of almitrine bismesylate in chronic obstructive airways disease vectarion international multicenter study group vims. American Review of Respiratory Disease 135(4 PART 2): A277, 1987

Almitrine bismesylate in chronic obstructive pulmonary disease. Medicina Clinica 100(9): 356-357, 1993

The assessment of almitrine bismesylate in the long-term treatment of chronic obstructive bronchitis. European Journal of Respiratory Diseases. Supplement 146: 685-693, 1986

The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease. Annals of Internal Medicine 105(3): 342-346, 1986

The effects of almitrine bismesylate in chronic obstructive pulmonary disease with CO2 retention. Zhonghua Nei Ke Za Zhi 29(8): 479-81, 511, 1990

Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease. European Respiratory Journal 7(5): 862-868, 1994

Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease. Chest 105(5): 1383-1391, 1994

Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease. European Journal of Respiratory Diseases. Supplement 126: 255-264, 1983

The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease patients living at moderate altitude. Current Therapeutic Research 43(2): 327-334, 1988

Reduction of nocturnal oxygen desaturation in chronic obstructive pulmonary disease patients treated with almitrine bismesylate. American Review of Respiratory Disease 133(4 SUPPL): A99, 1986